1. Carmeliet, F., Janssen, P.A.J., Marsboom, R., Van Nueten, J.M. and Xhonneux, R. (1978): Antiarrhythmic, electrophysiologic and hemodynamic effects of lorcainide. Archs int. Pharmacodyn. Ther.: 231, 104–130.
2. Kesteloot, H. and Stroobandt, R. (1977): Clinical experience with lorcainide (R IS 889), a new antiarrhythmic drug. Archs int. Pharmacodyn. Ther.: 230, 225–234.
3. Amery, W.K., Heykants, J.J.P., Xhonneux, R., Towse, G., Oettel, P., Gough, D.A. and Janssen, P.A.J. (1981): Lorcainide (R 15 889), a first review. Acta Cardiol.: 3, 207–234.
4. Meinertz, T., Kasper, W., Kersting, F., Bechtold, H., Just, H. and Jänchen, E. (1980): Antiarrhythmic effect of lorcainide during chronic treatment. Arzneimittel-Forsch.: 30, 1953–1595.
5. Klotz, U. and Golbs, E. (1980): The pharmacokinetics and tissue distribution of the new antiarrhythmic agent lorcainide (R 15 889) in rats. Artzneimittel-Forsch.: 30, 619–621.